Ensysce Biosciences Inc. logo

Ensysce Biosciences Inc.

ENSC | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.03 (-5.02%)
Sep 11, 2026, 4:00 PM ET · Market open

Market Data

Market Cap
$7.93M
Enterprise Value
$7M
Beta
0.99
Average Volume
6.02M
Shares Outstanding (Diluted)
13.04M
Shares Change YoY
491.91%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US2936025046

Price Performance

Price Change 1M
16.7%
Price Change 3M
81.5%
Price Change 6M
14.1%
Price Change YTD
-47.9%
Price Change 1Y
-77.0%
Price Change 3Y
-98.1%
Price Change 5Y
-100.0%
1M CAGR (ann.)
104.1%
1Y CAGR (ann.)
-75.7%
5Y CAGR (ann.)
-86.4%
All-Time CAGR
-72.9%

Valuation

PE Ratio
-0.19
Forward PE
N/A
PEG Ratio
0.01
Forward PEG
N/A
PS Ratio
6.43
Forward PS
3.00
PB Ratio
-9.57
P/FCF Ratio
-0.83
P/Adj. FCF Ratio
-0.83
P/OCF Ratio
-0.72
EV/Sales
6.01
EV/EBIT
-0.55
EV/EBITDA
-0.56
EV/FCF
-0.78
Earnings Yield
-514.3%
FCF Yield
-120.0%
Adj. FCF Yield
-121.0%

Financial Health

Net Cash
$479.86K
Total Debt
$196.84K
Cash & Short-Term Investments
$676.7K
Total Assets
$2.96M
Current Ratio
0.70
Quick Ratio
0.70
Debt / Equity Ratio
-0.25
Debt / EBITDA
-0.02
Debt / FCF
-0.02
OCF / Debt
-44.99
Interest Coverage
-791.64
Altman Z-Score
-82.06
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-1087.5%
EBITDA Margin
-1083.3%
Net Profit Margin
-1084.2%
FCF Margin
-771.2%
Adj. FCF Margin
-777.2%
SBC / Revenue
6.0%
SBC Impact (per share)
-0.8%

Returns

Return on Assets
-426.9%
Return on Equity
-1532.3%
Return on Invested Capital
1385.3%
Return on Capital Employed
1139.8%
Return on Tangible Assets
-426.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
32.4%
EPS CAGR 5Y
-162.1%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
18.6%
FCF CAGR 5Y
-107.2%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
N/A
Analyst Count
N/A
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 12, 2026
EPS Estimate (next Q)
-$0.19
EPS Growth Est (next Q)
-85.3%
Revenue Est (next Q)
$1.2M
Revenue Growth Est (next Q)
143.4%

Cash Flow

Operating Cash Flow
$-8.86M
Free Cash Flow
$-8.98M
Adj. Free Cash Flow
$-9.05M
FCF Per Share
-$0.69
OCF Per Share
-$0.68
OCF/S Ratio
-760.6%

Income Statement

Revenue
$1.16M
Gross Profit
$1.16M
Operating Income
$-12.66M
EBITDA
$-12.61M
Net Income
$-12.62M
EPS (Diluted)
-$2.52
Revenue / Employee
$166.33K
Profit / Employee
$-1.8M
Employees
7

© 2026 bestshares.com. All rights reserved.